Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Induced Pluripotent Stem Cells | 12 | 2021 | 584 | 2.25 | Why? |
| Retinal Ganglion Cells | 3 | 2019 | 80 | 0.95 | Why? |
| Cell Culture Techniques | 3 | 2021 | 704 | 0.84 | Why? |
| Cell Differentiation | 7 | 2019 | 1338 | 0.75 | Why? |
| Retina | 2 | 2021 | 424 | 0.74 | Why? |
| Organoselenium Compounds | 1 | 2019 | 123 | 0.70 | Why? |
| Gene Expression | 1 | 2021 | 3332 | 0.41 | Why? |
| Vitelliform Macular Dystrophy | 2 | 2019 | 13 | 0.39 | Why? |
| Dimethylpolysiloxanes | 2 | 2019 | 46 | 0.39 | Why? |
| Optic Atrophy, Hereditary, Leber | 2 | 2018 | 10 | 0.37 | Why? |
| Polymers | 2 | 2019 | 507 | 0.27 | Why? |
| Tongue Neoplasms | 1 | 2003 | 54 | 0.25 | Why? |
| Bestrophins | 2 | 2019 | 6 | 0.24 | Why? |
| Retinal Pigment Epithelium | 2 | 2019 | 62 | 0.23 | Why? |
| Cellular Reprogramming | 2 | 2018 | 117 | 0.21 | Why? |
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2019 | 5 | 0.20 | Why? |
| Genitalia | 1 | 2020 | 98 | 0.20 | Why? |
| DNA, Mitochondrial | 2 | 2018 | 163 | 0.20 | Why? |
| Nylons | 1 | 2019 | 34 | 0.19 | Why? |
| Intravitreal Injections | 1 | 2021 | 347 | 0.19 | Why? |
| Tissue Scaffolds | 2 | 2018 | 174 | 0.19 | Why? |
| Calcium Channels | 1 | 2019 | 96 | 0.19 | Why? |
| Arachidonate 12-Lipoxygenase | 1 | 2018 | 15 | 0.19 | Why? |
| Arachidonate 15-Lipoxygenase | 1 | 2018 | 9 | 0.19 | Why? |
| Spheroids, Cellular | 1 | 2019 | 124 | 0.19 | Why? |
| Chromosomes, Human, Pair 11 | 1 | 2018 | 16 | 0.19 | Why? |
| Genes, Mitochondrial | 1 | 2018 | 14 | 0.19 | Why? |
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 43 | 0.18 | Why? |
| alpha-Galactosidase | 1 | 2018 | 32 | 0.18 | Why? |
| Gene Transfer Techniques | 1 | 2019 | 134 | 0.18 | Why? |
| Eukaryotic Initiation Factor-2 | 1 | 2018 | 81 | 0.18 | Why? |
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2018 | 76 | 0.18 | Why? |
| Cytoplasmic Granules | 1 | 2018 | 53 | 0.18 | Why? |
| Oxides | 1 | 2018 | 77 | 0.18 | Why? |
| Neovascularization, Physiologic | 1 | 2019 | 160 | 0.17 | Why? |
| eIF-2 Kinase | 1 | 2018 | 117 | 0.17 | Why? |
| Axons | 1 | 2017 | 73 | 0.17 | Why? |
| Micronutrients | 1 | 2021 | 310 | 0.17 | Why? |
| Neoplastic Stem Cells | 1 | 2018 | 120 | 0.16 | Why? |
| Pluripotent Stem Cells | 1 | 2018 | 167 | 0.16 | Why? |
| Fabry Disease | 1 | 2018 | 106 | 0.16 | Why? |
| Stroke Rehabilitation | 1 | 2020 | 299 | 0.16 | Why? |
| Liposomes | 1 | 2019 | 334 | 0.16 | Why? |
| Fluorescent Antibody Technique | 1 | 2019 | 835 | 0.16 | Why? |
| Endometriosis | 1 | 2017 | 130 | 0.15 | Why? |
| Tissue Engineering | 1 | 2017 | 190 | 0.15 | Why? |
| Nerve Tissue Proteins | 1 | 2018 | 319 | 0.15 | Why? |
| Liver Failure, Acute | 1 | 2019 | 279 | 0.15 | Why? |
| Glioblastoma | 1 | 2018 | 187 | 0.14 | Why? |
| Secondary Prevention | 1 | 2020 | 762 | 0.14 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 436 | 0.14 | Why? |
| Hepatocytes | 1 | 2018 | 549 | 0.14 | Why? |
| Graphite | 1 | 2018 | 318 | 0.14 | Why? |
| Vaccines, Subunit | 1 | 2021 | 1088 | 0.14 | Why? |
| Organoids | 1 | 2021 | 840 | 0.14 | Why? |
| Carcinoma | 1 | 2017 | 256 | 0.14 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2019 | 451 | 0.14 | Why? |
| Drug Resistance, Neoplasm | 1 | 2018 | 447 | 0.13 | Why? |
| Vaccines, DNA | 1 | 2021 | 871 | 0.13 | Why? |
| Carcinoma, Squamous Cell | 1 | 2003 | 902 | 0.13 | Why? |
| Open Reading Frames | 1 | 2021 | 1898 | 0.13 | Why? |
| Curcumin | 1 | 2019 | 396 | 0.13 | Why? |
| Oxidative Stress | 3 | 2019 | 2050 | 0.13 | Why? |
| Reactive Oxygen Species | 1 | 2019 | 1136 | 0.13 | Why? |
| Apoptosis | 1 | 2003 | 2335 | 0.12 | Why? |
| Immunomodulation | 1 | 2021 | 1472 | 0.12 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.12 | Why? |
| Ovarian Neoplasms | 1 | 2017 | 465 | 0.12 | Why? |
| Myocytes, Cardiac | 1 | 2018 | 804 | 0.11 | Why? |
| Physical Therapy Modalities | 1 | 2020 | 1090 | 0.11 | Why? |
| RNA-Binding Proteins | 1 | 2018 | 1022 | 0.10 | Why? |
| Nanoparticles | 2 | 2019 | 2040 | 0.10 | Why? |
| Octamer Transcription Factor-3 | 2 | 2018 | 17 | 0.10 | Why? |
| SOXB1 Transcription Factors | 2 | 2018 | 20 | 0.09 | Why? |
| Chemokine CXCL10 | 1 | 2013 | 565 | 0.09 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.09 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.09 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Dexamethasone | 1 | 2019 | 2055 | 0.08 | Why? |
| Immunologic Factors | 2 | 2020 | 4206 | 0.08 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.08 | Why? |
| Epithelial Cells | 1 | 2019 | 3508 | 0.08 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.08 | Why? |
| Humans | 32 | 2021 | 930598 | 0.08 | Why? |
| Gastrointestinal Diseases | 1 | 2021 | 2580 | 0.07 | Why? |
| Vascular Endothelial Growth Factor A | 2 | 2020 | 604 | 0.07 | Why? |
| Peptidyl-Dipeptidase A | 3 | 2020 | 9659 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.07 | Why? |
| Skin Diseases | 1 | 2021 | 2509 | 0.07 | Why? |
| Proliferating Cell Nuclear Antigen | 1 | 2003 | 18 | 0.07 | Why? |
| In Situ Nick-End Labeling | 1 | 2003 | 39 | 0.07 | Why? |
| bcl-2-Associated X Protein | 1 | 2003 | 45 | 0.06 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.06 | Why? |
| Cell Division | 1 | 2003 | 136 | 0.06 | Why? |
| Immunohistochemistry | 2 | 2018 | 2275 | 0.06 | Why? |
| Pulmonary Fibrosis | 1 | 2013 | 1068 | 0.06 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 127 | 0.06 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.06 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.06 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.05 | Why? |
| Proto-Oncogene Proteins | 1 | 2003 | 340 | 0.05 | Why? |
| Active Transport, Cell Nucleus | 1 | 2020 | 203 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Cytoprotection | 1 | 2019 | 44 | 0.05 | Why? |
| Zonula Occludens-1 Protein | 1 | 2019 | 54 | 0.05 | Why? |
| Laminin | 1 | 2019 | 23 | 0.05 | Why? |
| Publication Bias | 1 | 2021 | 241 | 0.05 | Why? |
| Biotin | 1 | 2019 | 52 | 0.05 | Why? |
| Nanog Homeobox Protein | 1 | 2018 | 11 | 0.05 | Why? |
| Organelle Biogenesis | 1 | 2018 | 15 | 0.05 | Why? |
| Antiviral Agents | 3 | 2020 | 41703 | 0.05 | Why? |
| Karyotyping | 1 | 2018 | 52 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Neurites | 1 | 2017 | 26 | 0.05 | Why? |
| Dietary Supplements | 2 | 2021 | 2251 | 0.05 | Why? |
| Isoenzymes | 1 | 2018 | 127 | 0.05 | Why? |
| Mice, Inbred NOD | 1 | 2018 | 134 | 0.04 | Why? |
| Biomimetics | 1 | 2018 | 84 | 0.04 | Why? |
| Enzyme Replacement Therapy | 1 | 2018 | 65 | 0.04 | Why? |
| Hep G2 Cells | 1 | 2019 | 391 | 0.04 | Why? |
| Biomimetic Materials | 1 | 2018 | 70 | 0.04 | Why? |
| Coated Materials, Biocompatible | 1 | 2019 | 113 | 0.04 | Why? |
| Mice, SCID | 1 | 2018 | 225 | 0.04 | Why? |
| Kruppel-Like Transcription Factors | 1 | 2018 | 91 | 0.04 | Why? |
| Spectroscopy, Fourier Transform Infrared | 1 | 2018 | 207 | 0.04 | Why? |
| Phagocytosis | 1 | 2019 | 409 | 0.04 | Why? |
| Mice, Nude | 1 | 2018 | 340 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2019 | 605 | 0.04 | Why? |
| Cell Lineage | 1 | 2018 | 241 | 0.04 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.04 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.04 | Why? |
| Selenium | 1 | 2021 | 412 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Fertility | 1 | 2020 | 367 | 0.04 | Why? |
| Microarray Analysis | 1 | 2017 | 262 | 0.04 | Why? |
| Nutritional Support | 1 | 2020 | 447 | 0.04 | Why? |
| Macular Degeneration | 1 | 2019 | 194 | 0.04 | Why? |
| Materials Testing | 1 | 2018 | 380 | 0.04 | Why? |
| Iron | 1 | 2021 | 619 | 0.04 | Why? |
| Mutation Rate | 1 | 2018 | 382 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| DNA-Binding Proteins | 1 | 2018 | 469 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Hygiene | 1 | 2021 | 987 | 0.03 | Why? |
| Genes, myc | 1 | 2013 | 15 | 0.03 | Why? |
| Zinc | 1 | 2021 | 817 | 0.03 | Why? |
| Culture Media, Conditioned | 1 | 2013 | 66 | 0.03 | Why? |
| Mice | 3 | 2019 | 21357 | 0.03 | Why? |
| Pneumonia | 1 | 2013 | 5652 | 0.03 | Why? |
| Transcription Factors | 1 | 2018 | 784 | 0.03 | Why? |
| Neutrophil Infiltration | 1 | 2013 | 201 | 0.03 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.03 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.03 | Why? |
| Bleomycin | 1 | 2013 | 195 | 0.03 | Why? |
| Peroxidase | 1 | 2013 | 207 | 0.03 | Why? |
| Cell Proliferation | 1 | 2019 | 1973 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.03 | Why? |
| Nanotechnology | 1 | 2017 | 821 | 0.03 | Why? |
| Mitochondria | 1 | 2018 | 857 | 0.03 | Why? |
| Pandemics | 11 | 2020 | 389249 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.03 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.02 | Why? |
| Survival Analysis | 1 | 2003 | 7592 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 1510 | 0.02 | Why? |
| Survival Rate | 1 | 2003 | 9206 | 0.02 | Why? |
| Medicine, Chinese Traditional | 1 | 2020 | 2255 | 0.02 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.02 | Why? |
| Animals | 4 | 2019 | 78931 | 0.02 | Why? |
| Cells, Cultured | 1 | 2019 | 5835 | 0.02 | Why? |
| Electrocardiography | 1 | 2021 | 3957 | 0.02 | Why? |
| Patient Safety | 1 | 2021 | 4885 | 0.02 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.02 | Why? |
| Female | 6 | 2020 | 380317 | 0.02 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2003 | 17020 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Mice, Inbred C57BL | 1 | 2013 | 5542 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Male | 4 | 2020 | 367725 | 0.01 | Why? |
| Prognosis | 1 | 2003 | 32490 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Middle Aged | 3 | 2018 | 270681 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2013 | 10998 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Aged | 2 | 2018 | 215776 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Adult | 2 | 2018 | 244371 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Cytokines | 1 | 2013 | 15010 | 0.01 | Why? |
Yang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(206)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(85)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_